CYP46A1-Targeted Treatment Alleviates Long-Term White Matter Injury Following Traumatic Brain Injury by Promoting Cholesterol Metabolic Clearance and Remyelination. [PDF]
Li L +10 more
europepmc +1 more source
Integrating PBPK Simulation and In Vitro Pharmacodynamics to Model Efavirenz-Associated Hepatic Oxidative Stress in Pregnancy. [PDF]
Costa B, Gouveia MJ, Vale N.
europepmc +1 more source
Therapeutic Interventions in Niemann-Pick Disease Type C: A Systematic Review of Clinical Outcomes and Safety. [PDF]
Nafees Z +3 more
europepmc +1 more source
The Effect of Efavirenz and Rufinamide on the Pharmacokinetics and Safety of Quizartinib: Two Phase 1 Studies in Healthy Participants. [PDF]
Yoo Y +8 more
europepmc +1 more source
Pharmaco-economic profile, effectiveness, and safety of a dolutegravir based first line ART regimen among people living with HIV in South Gujarat. [PDF]
Sojitra B +8 more
europepmc +1 more source
One- and Two-Year Outcomes of Switching to a Dolutegravir-Based ART Regimen: An Observational Emulation of Sequential Target Trials. [PDF]
Zheng A +9 more
europepmc +1 more source
Comparative evaluation of human T lymphocytes in HIV patients treated with lamivudine + zidovudine combined with nevirapine versus efavirenz. [PDF]
Zhu X, Zou M.
europepmc +1 more source
Incidence Rate and Factors Associated with Antiretroviral Therapy Regimen Change among Adult HIV Patients at Ngoerah Hospital Bali, Indonesia. [PDF]
Somia IKA +4 more
europepmc +1 more source
The impact of dolutegravir on the growth of HIV-exposed uninfected infants: an observational cohort study in rural Tanzania. [PDF]
Glanzmann S +16 more
europepmc +1 more source
Efficacy and safety of TDF+3TC + EFV‑centric antiretroviral regimens for HIV/HBV co-infection: a systematic review and network meta‑analysis. [PDF]
Zhang X +6 more
europepmc +1 more source

